Literature DB >> 19863169

Elevated plasma levels of the angiogenic tetrapeptide acetyl-ser-asp-lys-pro are found in some patients with hematologic malignancies.

Jian-Miao Liu, Joanna Gora-Tybor, Olga Grzybowska-Izydorczyk, Jerome Bignon, Tadeusz Robak, Joanna Wdzieczak-Bakala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19863169     DOI： 10.3109/10428190903331074

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors.

Authors:  Megumi Kanasaki; Takako Nagai; Munehiro Kitada; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2011-11-30

Review 2.  N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes.

Authors:  Keizo Kanasaki; Takako Nagai; Kyoko Nitta; Munehiro Kitada; Daisuke Koya
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

3.  Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis.

Authors:  Enrico Conte; Evelina Fagone; Elisa Gili; Mary Fruciano; Maria Iemmolo; Maria Provvidenza Pistorio; Daniela Impellizzeri; Marika Cordaro; Salvatore Cuzzocrea; Carlo Vancheri
Journal:  Oncotarget       Date:  2016-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.